HIF1A and breast cancer: Our observation of selective (i.e., hypoxia-specific) transcriptional activation of JFK by HIF-1α is notable because JFK dysregulation/overexpression has been reported to be a frequent event in breast cancer and has been associated with especially aggressive clinical features and worse survival in breast cancer patients (Yan et al., 2015).